In this study, by the use of specific Rac1 inhibitor, Rac1 siRNA and mutant TIPE2 plasmid, we demonstrated that TIPE2 suppressed the migration, invasion, colony formation capacities and the angiogenesis of NSCLC via blocking Rac1 downstream signals. The gene discussed is TIPE2; the disease is non-small cell lung carcinoma.